TCL Archive ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position December 19, 2014
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
